Citation
Select
Hurria A1, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Bhatia S, Katheria V, Klapper S, Hansen K, Ramani R, Lachs M, Wong FL, Tew WP
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
J Clin Oncol. 2011 Sep 1;29(25):3457-6
Citation
Select
ARISTOTLE Committees and Investigators, Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L
Apixaban versus warfarin in patients with atrial fibrillation
N Engl J Med. 2011 Sep 15;365(11):981-92
Citation
Select
ACT Investigators ACT Investigators,
Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT).
Circulation. 2011 Sep 13;124(11):1250-9